Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Vyome Holdings, Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 5 | 8 | +3 |
| Shares | 24.3K | 93.7K | +69.5K (+286.2%) |
| Value | $125.4K | $322.3K | +$196.9K (+157.1%) |
New holders (5)
Institutions that held Vyome Holdings, Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 45,144 | $155.3K | 0.00% |
| Colony Group, LLC | 14,640 | $50.4K | 0.00% |
| Vanguard Group Inc | 12,195 | $42.0K | 0.00% |
| Geode Capital Management, LLC | 11,934 | $41.1K | 0.00% |
| Citigroup Inc | 1 | $3 | 0.00% |
Sold out (2)
Institutions that held Vyome Holdings, Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| HighTower Advisors, LLC | 17,973 | $93.1K |
| Morgan Stanley | 118 | $611 |